{"disease":{"id":"cervix-uteri-sil","name":"cervix uteri sil"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06147388","title":"Regression of Cervical Precancerous Lesions and Associated Risk Factors","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"General University Hospital, Prague","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}